Safety of pyridoxine — A review of human and animal studiesMarvin B. Cohen, Adrianne Bendich|Toxicology Letters|1986Cited by 75
Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK StudyRachael F. Grace, Bertil Glader, D. Holmes Morton et al.|Blood|2016Cited by 6
Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase DeficiencyRachael F. Grace, Bertil Glader, D. Mark Layton et al.|Blood|2017Cited by 2